BioSapien: Funding, Investors & Team (Oct 2026)
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline of indications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
BioSapien has raised $7.3M across 2 funding rounds on record, the most recent a Seed of $5.5M announced in Dec 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioSapien Company Profile and Key Stats
Latest funding round on record: Dec 2024.
BioSapien Funding Rounds
BioSapien raised $1.8M in a Seed announced in Nov 2021.
3.1 years later, a Seed of $5.5M was announced in Dec 2024.
BioSapien Founders and Leadership Team
No contact details are on record for this team yet.
BioSapien Funding Compared to Other Biotechnology Startups
BioSapien's latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioSapien in Biotechnology and New York
Companies Similar to BioSapien
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
BioSapien Funding FAQs
What does BioSapien do?
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline of indications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
How much funding has BioSapien raised?
BioSapien has raised $7.3M across 2 rounds on record. The most recent is a Seed of $5.5M announced in Dec 2024.
When did BioSapien last raise funding?
BioSapien's most recent funding round on record is a Seed of $5.5M, announced in Dec 2024.
Who founded BioSapien?
FundedIQ lists Khatija Ali (Founder) at BioSapien.
Where is BioSapien headquartered?
BioSapien is based in New York, United States.
How many employees does BioSapien have?
BioSapien is in the 1-10 employee band.
How does BioSapien's funding compare to other Biotechnology startups?
BioSapien's latest round of $5.5M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BioSapien Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioSapien is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.